GÖKCAN, H. Et Al. 2022. Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416). EASL The International Liver Congress , (London, Canada).

GÖKCAN, H., YAPALI, S., HARPUTLUOĞLU, M. M. M., MELEKOĞLU ELLİK, Z., GÖKÇEN, P., ADANIR, H., ... COŞAR, A. M.(2022). Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416) . EASL The International Liver Congress, London, Canada

GÖKCAN, HALE Et Al. "Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)," EASL The International Liver Congress, London, Canada, 2022

GÖKCAN, HALE Et Al. "Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)." EASL The International Liver Congress , London, Canada, 2022

GÖKCAN, H. Et Al. (2022) . "Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)." EASL The International Liver Congress , London, Canada.

@conferencepaper{conferencepaper, author={HALE GÖKCAN Et Al. }, title={Real life efficacy and tolerability of Tenofovir alafenamide fumarate in liver transplant recipients: a multicenter study (SAT416)}, congress name={EASL The International Liver Congress}, city={London}, country={Canada}, year={2022}}